C. Armanda Roco

C. Armanda Roco, PhD, is a Senior Manager of Molecular Research at Adaptive Biotechnologies Corp., leading advancements on the FDA-approved ClonoSEQ assay for measurable residual disease detection. With extensive experience in project management and team leadership, C. Armanda has contributed to the development of personalized T-cell therapeutic assays and optimization of immune system assays. Previous roles include Postdoctoral Scholar at Oregon State University, focusing on nitrogen turnover cycles, and Postdoctoral Research Associate at Cornell University, where expertise in soil microbial indicators was developed. C. Armanda earned a PhD in Microbiology from Cornell University, and holds a B.S. in Biology and Environmental Science from the University of Virginia.